The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza
Kolobukhina, L.V.; Burtseva, E.I.; Shelkanov, M.Iu.; Al'khovskiĭ, S.V.; Prilipov, A.G.; Merkulova, L.N.; Kisteneva, L.B.; Vartanian, R.V.; Kruzhkova, I.S.; Trushakova, S.V.; Krasnoslobodtsev, K.G.; Avdeev, S.M.; Sutochnikova, O.A.; Bazarova, M.V.; Kelly, E.I.; Ambrosi, O.E.; Malyshev, n.A.; L'vov, D.K.; Chuchalin, A.G.
Terapevticheskii arkhiv 86(10): 52-59
2014
ISSN/ISBN: 0040-3660 PMID: 25509893 Document Number: 675190
To characterize the 2013-2014 epidemic season from the results of detection of influenza infection in patients; to provide the molecular genetic characteristics of the strains isolated from deceased patients. The investigators examined 1203 patients (387 children, 509 people older than 16 years of age, 307 pregnant women) admitted to Moscow Clinical Infectious Diseases Hospital One with the clinical signs of acute respiratory viral diseases. Nasal lavage and autopsy specimens were used to isolate viral strains, then to sequence genomic fragments, and to determine receptor specificity. Out of the 1203 examinees, 284 (23.6%) were influenza-positive: 221 (77.8%), 24 (8.5%), and 39 (13.7%) patients had influenza A(H3N2), influenza A(H1N1)pdm09, and influenza B, respectively. Influenza was notified in 42,7% of the pregnant women. There was a preponderance of its moderate form; its severe form developed in single cases having comorbidities. One fatal outcome was registered. The intake of antiviral medications in the first 48 hours of the disease could prevent complications. The investigators revealed mutations in the strain isolated from the bronchoalveolar lavage fluid of a patient with severe pneumonia complicated by acute respiratory distress syndrome. There is evidence that there are mutant A(H1N1)pdm09 viruses that have high pneumotropicity. The high risk of their circulation in the population and the risk of severe influenza forms involving the lower respiratory tract remain. Early antiviral therapy in the first 36-48 hours diminishes the clinical manifestations of influenza and reduces the risk of developing complications.